Registered Nurse in Northern Mariana Islands Medicare Details, Address, Contact
7 Registered Nurse nurses found. Showing 1 - 7
 Rocel Cariaso, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Matsue Street, Chinatown,, Garapan Saipan, MP 96950 Phone: 670-483-6140 |
 Ms. Bodch Trinidad Camacho Ito, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Mariana Heights Business Park, Mh-ii Bldg Suite 100, Saipan, MP 96950 Phone: 671-475-5827 |
Gayline Patricia Blau, RN, BSN, NP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Lower Navy Hill, Saipan, MP 96950 Phone: 670-234-8950 |
Mr. Marc Joseph Bernal Dizon, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 6 Chalan Pale Arnold Rd, Gualo Rai Plaza, Saipan, MP 96950 Phone: 670-233-3647 |
Mr. Jordan Despabiladeras Danao, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Jabon Drive Apt 1 Gualo Rai, Saipan, MP 96950 Phone: 670-789-7965 |
Flaviana Saimon, Registered Nurse - Obstetric, Inpatient Medicare: Not Enrolled in Medicare Practice Location: 1 Lower Navy Hill Road, Navy Hill, Saipan, MP 96950 Phone: 670-234-8950 Fax: 670-236-8756 |
Douglas Miller, RRT, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Navy Hill, Saipan, MP 96950 Phone: 670-234-8950 |
News Archive
Patients with sarcopenia more likely to have worse outcomes from melanoma
It's not how old but how frail patients are that can predict how well they will fare after a melanoma diagnosis. In fact, young patients in poor health may have worse outcomes than older patients in good shape.
Pregnancy study finds strong association between two antidepressants and heart anomalies
Women who took the antidepressant fluoxetine during the first three months of pregnancy gave birth to four times as many babies with heart problems as women who did not and the levels were three times higher in women taking paroxetine.
Genzyme receives FDA approval for AUBAGIO to treat relapsing forms of MS
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has approved AUBAGIO (teriflunomide) as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).
AstraZeneca, Pharmacyclics partner to evaluate efficacy of IMBRUVICA for solid tumors
AstraZeneca and Pharmacyclics, Inc. today announced that they have entered into a clinical trial collaboration to evaluate a novel combination therapy targeting solid tumors.
› Verified 7 days ago